CANCER, LUNG
Clinical trials for CANCER, LUNG explained in plain language.
Never miss a new study
Get alerted when new CANCER, LUNG trials appear
Sign up with your email to follow new studies for CANCER, LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation approach aims to safely treat Hard-to-Reach lung tumors
Disease control Recruiting nowThis early-stage study tests a personalized radiation technique called PULSAR for lung cancers located near the center of the chest. The goal is to make treatment safer while still effectively controlling the tumor. About 30 adults with primary or metastatic lung cancer will rece…
Matched conditions: CANCER, LUNG
Phase: EARLY_PHASE1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New smart drug targets cancer cells in early trial
Disease control Recruiting nowThis early-phase trial tests CPO301, a drug designed to seek out and attack cancer cells that have a protein called EGFR on their surface. About 132 adults with advanced solid tumors (including lung, breast, and head & neck cancers) will receive the drug by IV every three weeks. …
Matched conditions: CANCER, LUNG
Phase: PHASE1 • Sponsor: Conjupro Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New program aims to boost quality of life for lung cancer survivors in rural areas
Symptom relief Recruiting nowThis study tests a special program designed to help people living in rural areas who have had lung cancer. The program focuses on improving quality of life, reducing stigma, and helping survivors stay engaged with their healthcare. About 300 participants will be randomly assigned…
Matched conditions: CANCER, LUNG
Phase: NA • Sponsor: Jerod L Stapleton, PhD • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Blood molecules may warn of chemo nerve pain
Knowledge-focused Recruiting nowThis study looks at whether tiny molecules in the blood, called microRNAs, can help predict how often and how severely cancer patients develop nerve damage from chemotherapy. Researchers will study 90 people receiving specific chemo drugs for lung or colon cancer. The goal is to …
Matched conditions: CANCER, LUNG
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
AI aims to revolutionize cancer trial enrollment for 50,000 patients
Knowledge-focused Recruiting nowThis study is testing whether an artificial intelligence (AI) tool can help match cancer patients with the right clinical trials. Researchers will enroll up to 50,000 people with various cancers to see if the AI improves trial enrollment rates and patient outcomes. The goal is to…
Matched conditions: CANCER, LUNG
Sponsor: Massive Bio, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC